Effects of Phenylacetylglutamine on the Susceptibility of Atrial Fibrillation in Overpressure-Induced HF Mice

References

• Mogensen UM, Jhund PS, Abraham WT, Desai AS, Dickstein K, Packer M, Rouleau JL, Solomon SD, Swedberg K, Zile MR, et al. Type of atrial fibrillation and outcomes in patients with heart failure and reduced ejection fraction. J Am Coll Cardiol. 2017;70:2490–2500. doi:10.1016/j.jacc.2017.09.027.
   PubMed Web of Science ®Google Scholar
• Scherr D, Jais P. Atrial fibrillation: AF prognosis and treatment–the European perspective. Nat Rev Cardiol. 2014;11:689–690. doi:10.1038/nrcardio.2014.171.
   PubMed Web of Science ®Google Scholar
• Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomström-Lundqvist C, Boriani G, Castella M, Dan G-A, Dilaveris PE, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021;42:373–498. doi:10.1093/eurheartj/ehaa612.
   PubMed Web of Science ®Google Scholar
• McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, Burri H, Butler J, Čelutkienė J, Chioncel O, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42:3599–3726. doi:10.1093/eurheartj/ehab368.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zhang S, Li B, Luo Y, Gong Y, Jin X, Zhang J, Zhou Y, Zhuo X, Wang Z, et al. Gut microbiota dysbiosis promotes age-related atrial fibrillation by lipopolysaccharide and glucose-induced activation of NLRP3-inflammasome. Cardiovasc Res. 2022;118:785–797. doi:10.1093/cvr/cvab114.
   PubMed Web of Science ®Google Scholar
• Kong B, Fu H, Xiao Z, Zhou Y, Shuai W, Huang H. Gut microbiota dysbiosis induced by a high-fat diet increases susceptibility to atrial fibrillation. Can J Cardiol. 2022;38:1962–1975. doi:10.1016/j.cjca.2022.08.231.
   PubMed Web of Science ®Google Scholar
• Liu Y, Liu S, Zhao Z, Song X, Qu H, Liu H. Phenylacetylglutamine is associated with the degree of coronary atherosclerotic severity assessed by coronary computed tomographic angiography in patients with suspected coronary artery disease. Atherosclerosis. 2021;333:75–82. doi:10.1016/j.atherosclerosis.2021.08.029.
   PubMed Web of Science ®Google Scholar
• Bartolomaeus H, Balogh A, Yakoub M, Homann S, Markó L, Höges S, Tsvetkov D, Krannich A, Wundersitz S, Avery EG, et al. Short-chain fatty acid propionate protects from hypertensive cardiovascular damage. Circulation. 2019;139:1407–1421. doi:10.1161/CIRCULATIONAHA.118.036652.
   PubMed Web of Science ®Google Scholar
• Choucair I, Nemet I, Li L, Cole MA, Skye SM, Kirsop JD, Fischbach MA, Gogonea V, Brown JM, Tang WHW, et al. Quantification of bile acids: a mass spectrometry platform for studying gut microbe connection to metabolic diseases. J Lipid Res. 2020;61:159–177. doi:10.1194/jlr.RA119000311.
   PubMed Web of Science ®Google Scholar
• Trøseid M, Ueland T, Hov JR, Svardal A, Gregersen I, Dahl CP, Aakhus S, Gude E, Bjørndal B, Halvorsen B, et al. Microbiota-dependent metabolite trimethylamine-N-oxide is associated with disease severity and survival of patients with chronic heart failure. J Intern Med. 2015;277:717–726. doi:10.1111/joim.12328.
   PubMed Web of Science ®Google Scholar
• Yang S, Li X, Yang F, Zhao R, Pan X, Liang J, Tian L, Li X, Liu L, Xing Y, et al. Gut microbiota-dependent marker TMAO in promoting cardiovascular disease: inflammation mechanism, clinical prognostic, and potential as a therapeutic target. Front Pharmacol. 2019;10:1360. doi:10.3389/fphar.2019.01360.
   PubMed Web of Science ®Google Scholar
• Guan B, Tong J, Hao H, Yang Z, Chen K, Xu H, Wang A. Bile acid coordinates microbiota homeostasis and systemic immunometabolism in cardiometabolic diseases. Acta Pharm Sin B. 2022;12:2129–2149. doi:10.1016/j.apsb.2021.12.011.
   PubMed Web of Science ®Google Scholar
• Romano KA, Nemet I, Prasad Saha P, Haghikia A, Li XS, Mohan ML, Lovano B, Castel L, Witkowski M, Buffa JA, et al. Gut Microbiota-Generated Phenylacetylglutamine and Heart Failure. Circ Heart Fail. 2023;16:e009972. doi:10.1161/CIRCHEARTFAILURE.122.009972.
   PubMed Web of Science ®Google Scholar
• Nemet I, Saha PP, Gupta N, Zhu W, Romano KA, Skye SM, Cajka T, Mohan ML, Li L, Wu Y, et al. A cardiovascular disease-linked gut microbial metabolite acts via adrenergic receptors. Cell. 2020;180:862–877.e22. doi:10.1016/j.cell.2020.02.016.
   PubMed Web of Science ®Google Scholar
• Wei H, Wu J, Wang H, Huang J, Li C, Zhang Y, Song Y, Zhou Z, Sun Y, Xiao L, et al. Increased circulating phenylacetylglutamine concentration elevates the predictive value of cardiovascular event risk in heart failure patients. J Intern Med. 2023;294:515–530. doi:10.1111/joim.13653.
   PubMed Web of Science ®Google Scholar
• Fang C, Zuo K, Jiao K, Zhu X, Fu Y, Zhong J, Xu L, Yang X. PAGln, an atrial fibrillation-linked gut microbial metabolite, acts as a promoter of atrial myocyte injury. Biomolecules. 2022;12:1120. doi:10.3390/biom12081120.
   PubMed Web of Science ®Google Scholar
• Marrouche NF, Brachmann J, Andresen D, Siebels J, Boersma L, Jordaens L, Merkely B, Pokushalov E, Sanders P, Proff J, et al. Catheter ablation for atrial fibrillation with heart failure. N Engl J Med. 2018;378:417–427. doi:10.1056/NEJMoa1707855.
   PubMed Web of Science ®Google Scholar
• Verma A, Kalman JM, Callans DJ. Treatment of patients with atrial fibrillation and heart failure with reduced ejection fraction. Circulation. 2017;135:1547–1563. doi:10.1161/CIRCULATIONAHA.116.026054.
   PubMed Web of Science ®Google Scholar
• Kotecha D, Piccini JP. Atrial fibrillation in heart failure: what should we do? Eur Heart J. 2015;36:3250–3257. doi:10.1093/eurheartj/ehv513.
   PubMed Web of Science ®Google Scholar
• Jalife J, Kaur K. Atrial remodeling, fibrosis, and atrial fibrillation. Trends Cardiovasc Med. 2015;25:475–484. doi:10.1016/j.tcm.2014.12.015.
   PubMed Web of Science ®Google Scholar
• Shiroshita-Takeshita A, Brundel BJJM, Burstein B, Leung T-K, Mitamura H, Ogawa S, Nattel S. Effects of simvastatin on the development of the atrial fibrillation substrate in dogs with congestive heart failure. Cardiovasc Res. 2007;74:75–84. doi:10.1016/j.cardiores.2007.01.002.
   PubMed Web of Science ®Google Scholar
• Wijesurendra RS, Casadei B. Mechanisms of atrial fibrillation. Heart. 2019;105:1860–1867. doi:10.1136/heartjnl-2018-314267.
   PubMed Web of Science ®Google Scholar
• McCauley MD, Hong L, Sridhar A, Menon A, Perike S, Zhang M, da Silva IB, Yan J, Bonini MG, Ai X, et al. Ion channel and structural remodeling in obesity-mediated atrial fibrillation. Circ Arrhythm Electrophysiol. 2020;13:e008296. doi:10.1161/CIRCEP.120.008296.
   PubMed Web of Science ®Google Scholar
• Iwasaki Y-k, Nishida K, Kato T, Nattel S. Atrial fibrillation pathophysiology: implications for management. Circulation. 2011;124:2264–2274. doi:10.1161/CIRCULATIONAHA.111.019893.
   PubMed Web of Science ®Google Scholar
• Shuai W, Kong B, Fu H, Shen C, Jiang X, Huang H. MD1 deficiency promotes inflammatory atrial remodelling induced by high-fat diets. Can J Cardiol. 2019;35:208–216. doi:10.1016/j.cjca.2018.11.020.
   PubMed Web of Science ®Google Scholar
• Ashihara T, Haraguchi R, Nakazawa K, Namba T, Ikeda T, Nakazawa Y, Ozawa T, Ito M, Horie M, Trayanova NA, et al. The role of fibroblasts in complex fractionated electrograms during persistent/permanent atrial fibrillation: implications for electrogram-based catheter ablation. Circ Res. 2012;110:275–284. doi:10.1161/CIRCRESAHA.111.255026.
   PubMed Web of Science ®Google Scholar
• Hunter RJ, Liu Y, Lu Y, Wang W, Schilling RJ. Left atrial wall stress distribution and its relationship to electrophysiologic remodeling in persistent atrial fibrillation. Circ Arrhythm Electrophysiol. 2012;5:351–360. doi:10.1161/CIRCEP.111.965541.
   PubMed Web of Science ®Google Scholar
• Sanders P, Kistler PM, Morton JB, Spence SJ, Kalman JM. Remodeling of sinus node function in patients with congestive heart failure: reduction in sinus node reserve. Circulation. 2004;110:897–903. doi:10.1161/01.CIR.0000139336.69955.AB.
   PubMed Web of Science ®Google Scholar
• Dobrzynski H, Boyett MR, Anderson RH. New insights into pacemaker activity: promoting understanding of sick sinus syndrome. Circulation. 2007;115:1921–1932. doi:10.1161/CIRCULATIONAHA.106.616011.
   PubMed Web of Science ®Google Scholar
• Verheule S, Wilson EE, Arora R, Engle SK, Scott LR, Olgin JE. Tissue structure and connexin expression of canine pulmonary veins. Cardiovasc Res. 2002;55:727–738. doi:10.1016/s0008-6363(02)00490-x.
   PubMed Web of Science ®Google Scholar
• Fujiwara K, Tanaka H, Mani H, Nakagami T, Takamatsu T. Burst emergence of intracellular Ca2+ waves evokes arrhythmogenic oscillatory depolarization via the Na+-Ca2+ exchanger: simultaneous confocal recording of membrane potential and intracellular Ca2+ in the heart. Circ Res. 2008;103:509–518. doi:10.1161/CIRCRESAHA.108.176677.
   PubMed Web of Science ®Google Scholar
• Zuo K, Li J, Li K, Hu C, Gao Y, Chen M, Hu R, Liu Y, Chi H, Wang H, et al. Disordered gut microbiota and alterations in metabolic patterns are associated with atrial fibrillation. Gigascience. 2019;8(6):giz058. doi:10.1093/gigascience/giz058.
   PubMed Web of Science ®Google Scholar
• Shen G, Wu J, Ye B-C, Qi N. Gut microbiota-derived metabolites in the development of diseases. Can J Infect Dis Med Microbiol. 2021;2021:6658674. doi:10.1155/2021/6658674.
   PubMed Web of Science ®Google Scholar
• Lin T, Li K, He W, Chen L, Wang T, Wang N. Trimethylamine N-oxide: A new therapeutic target for atrial fibrillation? Int J Cardiol. 2019;274:194. doi:10.1016/j.ijcard.2018.07.147.
   PubMed Web of Science ®Google Scholar
• Yu F, Li X, Feng X, Wei M, Luo Y, Zhao T, Xiao B, Xia J. Phenylacetylglutamine, a novel biomarker in acute ischemic stroke. Front Cardiovasc Med. 2021;8:798765. doi:10.3389/fcvm.2021.798765.
   PubMed Web of Science ®Google Scholar
• Dodd D, Spitzer MH, Van Treuren W, Merrill BD, Hryckowian AJ, Higginbottom SK, Le A, Cowan TM, Nolan GP, Fischbach MA, et al. A gut bacterial pathway metabolizes aromatic amino acids into nine circulating metabolites. Nature. 2017;551:648–652. doi:10.1038/nature24661.
   PubMed Web of Science ®Google Scholar
• Liu B-Y, Li L, Liu G-L, Ding W, Chang W-G, Xu T, Ji X-Y, Zheng X-X, Zhang J, Wang J-X, et al. Baicalein attenuates cardiac hypertrophy in mice via suppressing oxidative stress and activating autophagy in cardiomyocytes. Acta Pharmacol Sin. 2021;42:701–714. doi:10.1038/s41401-020-0496-1.
   PubMed Web of Science ®Google Scholar
• Cao N, Wang J-J, Wu J-M, Xu W-L, Wang R, Chen X-d, Feng Y-N, Cong W-W, Zhang Y-Y, Xiao H, et al. Glibenclamide alleviates beta adrenergic receptor activation-induced cardiac inflammation. Acta Pharmacol Sin. 2022;43:1243–1250. doi:10.1038/s41401-021-00734-0.
   PubMed Web of Science ®Google Scholar
• Ren X, Wang X, Yuan M, Tian C, Li H, Yang X, Li X, Li Y, Yang Y, Liu N, et al. Mechanisms and treatments of oxidative stress in atrial fibrillation. Curr Pharm Des. 2018;24:3062–3071. doi:10.2174/1381612824666180903144042.
   PubMed Web of Science ®Google Scholar
• Mesubi OO, Anderson ME. Atrial remodelling in atrial fibrillation: CaMKII as a nodal proarrhythmic signal. Cardiovasc Res. 2016;109:542–557. doi:10.1093/cvr/cvw002.
   PubMed Web of Science ®Google Scholar
• Peng J, Liu Y, Xiong X, Huang C, Mei Y, Wang Z, Tang Y, Ye J, Kong B, Liu W, et al. Loss of MD1 exacerbates pressure overload-induced left ventricular structural and electrical remodelling. Sci Rep. 2017;7:5116. doi:10.1038/s41598-017-05379-w.
   PubMed Web of Science ®Google Scholar
• Fu H, Kong B, Zhu J, Huang H, Shuai W. Phenylacetylglutamine increases the susceptibility of ventricular arrhythmias in heart failure mice by exacerbated activation of the TLR4/AKT/mTOR signaling pathway. Int Immunopharmacol. 2023;116:109795. doi:10.1016/j.intimp.2023.109795.
   PubMed Web of Science ®Google Scholar
• Kondo H, Kira S, Oniki T, Gotoh K, Fukui A, Abe I, Ikebe Y, Kawano K, Saito S, Aoki K, et al. Interleukin-10 treatment attenuates sinus node dysfunction caused by streptozotocin-induced hyperglycaemia in mice. Cardiovasc Res. 2019;115:57–70. doi:10.1093/cvr/cvy162.
   PubMed Web of Science ®Google Scholar